520A — J-Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for J-Pharma, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Yuho
Standards:	JAS	JAS	JAS
Status:	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,073	2,302	4,453
Net Total Receivables	23.9	16.2	46.9
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,190	2,839	4,753
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0	0
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,207	2,857	4,761
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	200	452	378
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	257	479	383
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	950	2,378	4,378
Total Liabilities & Shareholders' Equity	1,207	2,857	4,761
Total Common Shares Outstanding